share_log

MannKind | 8-K: MANNKIND CORPORATION REPORTS 2024 SECOND QUARTER FINANCIAL RESULTS: PROVIDES CLINICAL DEVELOPMENT UPDATE Conference Call to Begin Today at 9:00 a.m. (ET)

MannKind | 8-K: MANNKIND CORPORATION REPORTS 2024 SECOND QUARTER FINANCIAL RESULTS: PROVIDES CLINICAL DEVELOPMENT UPDATE Conference Call to Begin Today at 9:00 a.m. (ET)

曼恩凯德生物医疗 | 8-K:MANNKIND CORPORATION公布2024年第二季度财务业绩:提供临床开发最新电话会议,将于今天上午9点(美国东部时间)开始
美股SEC公告 ·  2024/08/07 20:11
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息